Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Recommendation of “Hold” by Brokerages

Simulations Plus, Inc. (NASDAQ:SLP) has been assigned a consensus rating of “Hold” from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $24.40.

A number of analysts have recently weighed in on the stock. TD Cowen cut their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a report on Friday, April 10th. Wall Street Zen downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating in a report on Saturday, April 4th. Citigroup reaffirmed a “market perform” rating on shares of Simulations Plus in a report on Tuesday, January 6th. Finally, Zacks Research downgraded shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd.

Simulations Plus Stock Up 5.2%

Shares of NASDAQ:SLP opened at $14.91 on Monday. The company’s 50 day moving average price is $12.71 and its two-hundred day moving average price is $15.86. Simulations Plus has a 12-month low of $11.09 and a 12-month high of $34.07. The firm has a market cap of $301.18 million, a PE ratio of -4.76 and a beta of 1.28.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The company had revenue of $24.29 million during the quarter, compared to the consensus estimate of $21.66 million. On average, research analysts expect that Simulations Plus will post 0.85 EPS for the current year.

Hedge Funds Weigh In On Simulations Plus

Institutional investors have recently added to or reduced their stakes in the stock. North Star Investment Management Corp. increased its position in Simulations Plus by 195.6% during the 3rd quarter. North Star Investment Management Corp. now owns 168,130 shares of the technology company’s stock worth $2,534,000 after purchasing an additional 111,255 shares in the last quarter. Tributary Capital Management LLC increased its position in Simulations Plus by 214.7% during the 3rd quarter. Tributary Capital Management LLC now owns 1,136,980 shares of the technology company’s stock worth $17,134,000 after purchasing an additional 775,704 shares in the last quarter. Royce & Associates LP increased its position in Simulations Plus by 31.6% during the 3rd quarter. Royce & Associates LP now owns 348,758 shares of the technology company’s stock worth $5,256,000 after purchasing an additional 83,758 shares in the last quarter. Tudor Investment Corp ET AL acquired a new position in Simulations Plus during the 3rd quarter worth approximately $1,810,000. Finally, JPMorgan Chase & Co. increased its position in Simulations Plus by 154.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 167,646 shares of the technology company’s stock worth $2,526,000 after purchasing an additional 101,822 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.